Screener
United Therapeutics UTHR Capital investments accrued but not yet paid
Capital investments accrued but not yet paid at other companies
Other financials
Where this comes from
Reported directly by United Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.
The source filing: United Therapeutics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001082554-26-000027
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Cash and cash equivalents, beginning of period | 1,557.1 | 1,697.2 |
| Cash and cash equivalents, end of period | $1,803.2 | $1,593.1 |
| Supplemental cash flow information: | ||
| Cash paid for interest | $3.8 | $9.6 |
| Cash paid for income taxes | $102.5 | $253.9 |
| Non-cash investing and financing activities: | ||
| Non-cash additions to property, plant, and equipment | $104.1 | $66.2 |
| Excise tax on net share repurchase | $5.4 | — |
Item 1. Consolidated Financial Statements
FAQ
- What is United Therapeutics's capital investments accrued but not yet paid?
- United Therapeutics (UTHR) reported capital investments accrued but not yet paid of $4.5M in Q2 2026.
- How has United Therapeutics's capital investments accrued but not yet paid changed year-over-year?
- United Therapeutics's capital investments accrued but not yet paid decreased by 76.3% year-over-year, from $19M to $4.5M.
- What does capital investments accrued but not yet paid mean?
- Capital investments accrued but not yet paid
Ask your AI about United Therapeutics's capital investments accrued but not yet paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude